Singal, Amit G. http://orcid.org/0000-0002-1172-3971
Kanwal, Fasiha
Llovet, Josep M. http://orcid.org/0000-0003-0547-2667
Article History
Accepted: 25 September 2023
First Online: 26 October 2023
Competing interests
: A.G.S. has served as a consultant or on advisory boards for AstraZeneca, Bayer, Boston Scientific, Eisai, Exact Sciences, Exelixis, Freenome, FujiFilm Medical Sciences, Genentech, Glycotest, GRAIL, Roche and TARGET RWE. J.M.L. has received research support from from Bayer, Bristol-Myers Squibb, Eisai and Ipsen, and has received consultancy fees from AstraZeneca, Bayer, Bluejay Therapeutics, Boston Scientific, Bristol-Myers Squibb, Captor Therapeutics, Eisai, Eli Lilly, Exelixis, Genentech, Glycotest, Ipsen, Merck, Mina Alpha, Omega Therapeutics and Roche. F.K. declares no competing interests.